HBM Healthcare Investments AG

HBMN:SWX

HBM Healthcare Investments AG

Actions
  • Price (CHF)222.00
  • Today's Change-2.00 / -0.90%
  • Shares traded8.08k
  • 1 Year change+19.10%
  • Beta0.9372
Data delayed at least 15 minutes, as of Feb 17 2026 16:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CHFIncome statement in CHFView more

Year on year HBM Healthcare Investments AG grew revenues 81.12% from 23.19m to 42.01m while net income improved from a loss of 1.08m to a gain of 18.54m.
Gross margin91.97%
Net profit margin90.85%
Operating margin91.36%
Return on assets12.19%
Return on equity13.38%
Return on investment12.67%
More ▼

Cash flow in CHFView more

In 2025, cash reserves at HBM Healthcare Investments AG fell by 7.75m. However, Cash Flow from Investing totalled 73.00m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 2.36m for operations while cash used for financing totalled 78.39m.
Cash flow per share--
Price/Cash flow per share--
Book value per share280.87
Tangible book value per share280.87
More ▼

Balance sheet in CHFView more

HBM Healthcare Investments AG has a Debt to Total Capital ratio of 8.57%, a higher figure than the previous year's 5.85%.
Current ratio0.075
Quick ratio--
Total debt/total equity0.0938
Total debt/total capital0.0857
More ▼

Growth rates in CHF

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 1,844.07%. Additionally when measured on a five year annualized basis, dividend per share growth is in-line with the industry average relative to its peers, while earnings per share growth is below the industry average.
Div yield(5 year avg)3.49%
Div growth rate (5 year)-0.52%
Payout ratio (TTM)21.89%
EPS growth(5 years)-36.44
EPS (TTM) vs
TTM 1 year ago
10.66
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.